Relief of inflammation and pain in acute and chronic musculoskeletal disorders in dogs.
Active substance: Meloxicam
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam group, which acts by inhibiting the synthesis of prostaglandins, thereby exercising anti-inflammatory, analgesic, anti-exudative and antipyretic effects. Reduces leukocyte infiltration into inflamed tissue. To a lesser extent, it also inhibits thrombocyte aggregation induced by collagen. In vitro and in vivo studies have shown that meloxicam inhibits cyclooxygenase-2 (COX-2) to a greater extent than cyclooxygenase-1 (COX-1).
Posology and route of administration:
Oral use. Administer mixed with food or directly in the mouth. Shake well before use.
The initial treatment is a single dose of 0.2 mg meloxicam / kg body weight on the first day. Treatment should continue with oral administration once daily (at 24-hour intervals), at a maintenance dose of 0.1 mg meloxicam / kg body weight.
For more prolonged treatment, and once the clinical response is observed (after ≥ 4 days), the dose of the veterinary medicinal product can be adjusted to the lowest effective individual dose, reflecting that the degree of pain and inflammation associated with muscle diseases. Chronic skeletal disorders may vary over time.
The clinical response is usually seen within 3 - 4 days. Treatment should be stopped after a maximum of 10 days, if no clinical improvement is apparent.
Because it is a veterinary medicinal product subject to medical prescription, we request to send it to the email: online@farmacianovadamaia.pt
check_circle
check_circle
error Your review appreciation cannot be sent
feedback Report comment
check_circle Report sent
error Your report cannot be sent
Write your review
check_circle Review sent
error Your review cannot be sent